Drug therapy in cardiac arrest: a review of the literature
- PMID: 27533062
- DOI: 10.1093/ehjcvp/pvv047
Drug therapy in cardiac arrest: a review of the literature
Abstract
The aim of this study was to review the literature on human studies of drug therapy in cardiac arrest during the last 25 years. In May 2015, a systematic literature search was performed in PubMed, Embase, the Cochrane Library, and CRD databases. Prospective interventional and observational studies evaluating a specified drug therapy in human cardiac arrest reporting a clinical endpoint [i.e. return of spontaneous circulation (ROSC) or survival] and published in English 1990 or later were included, whereas animal studies, case series and reports, studies of drug administration, drug pharmacology, non-specified drug therapies, preventive drug therapy, drug administration after ROSC, studies with primarily physiological endpoints, and studies of traumatic cardiac arrest were excluded. The literature search identified a total of 8936 articles. Eighty-eight articles met our inclusion criteria and were included in the review. We identified no human study in which drug therapy, compared with placebo, improved long-term survival. Regarding adrenaline and amiodarone, the drugs currently recommended in cardiac arrest, two prospective randomized placebo-controlled trials, were identified for adrenaline, and one for amiodarone, but they were all underpowered to detect differences in survival to hospital discharge. Of all reviewed studies, only one recent prospective study demonstrated improved neurological outcome with one therapy over another using a combination of vasopressin, steroids, and adrenaline as the intervention compared with standard adrenaline administration. The evidence base for drug therapy in cardiac arrest is scarce. However, many human studies on drug therapy in cardiac arrest have not been powered to identify differences in important clinical outcomes such as survival to hospital discharge and favourable neurological outcome. Efforts are needed to initiate large multicentre prospective randomized clinical trials to evaluate both currently recommended and future drug therapies.
Keywords: Cardiac arrest; Drug therapy.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com.
Similar articles
-
Vasopressin in cardiac arrest.Ann Pharmacother. 2005 Oct;39(10):1687-92. doi: 10.1345/aph.1G187. Epub 2005 Aug 23. Ann Pharmacother. 2005. PMID: 16118265 Review.
-
Intravenous vs intraosseous adrenaline administration in cardiac arrest: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 Dec 24;99(52):e23917. doi: 10.1097/MD.0000000000023917. Medicine (Baltimore). 2020. PMID: 33350794 Free PMC article.
-
Comparison the efficacy of amiodarone and lidocaine for cardiac arrest: A network meta-analysis.Medicine (Baltimore). 2023 Apr 14;102(15):e33195. doi: 10.1097/MD.0000000000033195. Medicine (Baltimore). 2023. PMID: 37058064 Free PMC article.
-
Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomised double-blind placebo-controlled trial.Resuscitation. 2011 Sep;82(9):1138-43. doi: 10.1016/j.resuscitation.2011.06.029. Epub 2011 Jul 2. Resuscitation. 2011. PMID: 21745533 Clinical Trial.
-
Improving vasopressor use in cardiac arrest.Crit Care. 2023 Mar 2;27(1):81. doi: 10.1186/s13054-023-04301-3. Crit Care. 2023. PMID: 36864469 Free PMC article. Review.
Cited by
-
Levosimendan improves central haemodynamic status and gas exchange in a model of ischaemic cardiac arrest: A large animal study.Eur J Anaesthesiol. 2025 Jun 1;42(6):518-526. doi: 10.1097/EJA.0000000000002144. Epub 2025 Feb 17. Eur J Anaesthesiol. 2025. PMID: 39962856 Free PMC article.
-
Drug use during adult advanced cardiac life support: An overview of reviews.Resusc Plus. 2021 Aug 13;7:100156. doi: 10.1016/j.resplu.2021.100156. eCollection 2021 Sep. Resusc Plus. 2021. PMID: 34430950 Free PMC article. Review.
-
Review of novel therapeutics in cardiac arrest (ReNTICA): systematic review protocol.BMJ Open. 2022 Jan 3;12(1):e053304. doi: 10.1136/bmjopen-2021-053304. BMJ Open. 2022. PMID: 34980619 Free PMC article.
-
Pharmacological Approach for Neuroprotection After Cardiac Arrest-A Narrative Review of Current Therapies and Future Neuroprotective Cocktail.Front Med (Lausanne). 2021 May 18;8:636651. doi: 10.3389/fmed.2021.636651. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34084772 Free PMC article. Review.
-
High-dose intranasal insulin in an adaptive dose-escalation study in healthy human participants.Clin Transl Sci. 2024 Nov;17(11):e70071. doi: 10.1111/cts.70071. Clin Transl Sci. 2024. PMID: 39558506 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous